IBDHorizons June 24th Oklahoma Dialogue
Navigating UC Therapies Today
Moderated by Dr. Anita Afzali and Dr. Tauseef Ali
Based on emerging data, new publications, and the latest developments at the recent national and international IBD meetings, the program will focus on a practical approach to managing adults with IBD. Given the expansive therapeutic options, the discussion will follow a CD or UC case from diagnosis onwards with the goal of sharing experience between the moderators and attendees. Both moderators bring wide expertise as experts in the field of IBD. Discussions will be case-based regarding treatment pipeline, safety and durability of therapies, and positioning of therapies.
Program Details:
- Date: Thursday, June 24, 2021
- Time: 6:00 to 8:00 PM
- Location: Virtual IBDHorizons platform
- Attendees: 15-20 physician attendees
- Dinner: provider via local venues
- Non-CME accredited program
- Format: Main session with no breakout rooms, program not recorded
Moderators:
- Dr. Anita Afzali, Associate Professor of Medicine, Medical Director – OSU Inflammatory Bowel Disease Center, Columbus, OH
- Dr. Tauseef Ali – SSM Health St. Anthony Hospital, Oklahoma City, OK
Not local?
Contact [email protected] to find out how we can bring a Dialogue to you.
- Accreditation: Non-accredited
-
Supporters:
Justin Morris Key Account Manager – Texas/Oklahoma
Takeda Pharmaceuticals U.S.A, Inc.
Mobile: 940-339-6496
Email: [email protected]
George Tosh District Business Manager-Dallas, TX-Pfizer Inc
[email protected] 727-267-7569
Date
Time
Location
Speakers
-
Anita Afzali, MD, MPH, MHCMProfessor of Medicine in the Division of Digestive Diseases, Executive Vice Chair of Medicine in the Department of Internal Medicine at the University of Cincinnati College of Medicine, Associate Chief Medical Officer of the UC Health System
Dr. Anita Afzali is a Professor of Medicine in the Division of Digestive Diseases and Executive Vice Chair of Medicine in the Department of Internal Medicine at the University of Cincinnati College of Medicine. She is also the Associate Chief Medical Officer of the UC Health System. She received her medical degree and then completed Internal Medicine residency and gastroenterology fellowship at the University of Washington in Seattle, WA. While in fellowship, Dr. Afzali worked in outcomes research and epidemiology, and graduated with a Masters in Public Health from The University of Washington. She then later obtained another Masters In Healthcare Management (MHCM) from Harvard T.H. Chan School of Public Health. Her sub-specialty training includes a one-year advanced IBD fellowship at the University of Washington, prior to becoming faculty.
While practicing at the University of Washington – Harborview Medical Center, Dr. Afzali served as the Director of the IBD Program and Associate Medical Director of Gastroenterology Clinics. After Seattle, Dr. Afzali moved to Columbus, OH to be the Medical Director of The OSU IBD Center and the Vice Chair of Clinical Operations of Gastroenterology at The Ohio State University.
Recently, she has transitioned to the University of Cincinnati where she serves as the Executive Vice Chair of the Department of Internal Medicine. Her research interests include drug study design, investigational drug trials, and clinical outcomes. She has extensive peer-reviewed publications, an invited lecturer on national and international programs, and serves on several international advisory boards and committees including Chair of the American College of Gastroenterology (ACG) Educational Affairs Committee and Vice Chair of Publications Committee for the World Gastroenterology Organization (WGO).
-
Tauseef Ali, MDMD, MPH, FACG, Consultant Gastroenterologist, Clinical Assistant Professor of Medicine
Dr. Tauseef Ali is a consultant gastroenterologist at SSM Health Saint Anthony Hospital. He is also a Clinical Assistant Professor of Medicine at the University of Oklahoma in the section of Digestive Disease and Nutrition and adjunct faculty at Oklahoma State University. He is the chief of the Gastroenterology Section at SSM Health Saint Anthony Hospital, Oklahoma, where he also serves as director of IBD Clinical and Research program. Dr. Ali graduated from King Edward Medical College, Pakistan (2001). He completed his internal medicine residency (2006) and Gastroenterology fellowship (2009) program from the University of Oklahoma Health Sciences Center. He was also selected as the CCF visiting IBD fellow at the University of Chicago (2008).
His clinical interest includes Inflammatory Bowel Disease. He was the recipient of the AGA Bridges to Excellence Award to provide quality service to IBD patients. He is the author of Crohn’s and Colitis for Dummies book by Wiley Publishers. He is a fellow member of the American College of Gastroenterology (ACG) and has served on ACG International Relations, Training, Educational Affairs, Bylaws, membership and Public Relations Committees.
Dr. Ali is currently serving as the Chair of the American College of Gastroenterology Public Relations Committee. He has been the recipient of the ACG United States and World Gastroenterology Train the Trainers Program Travel Award. He has served as section editor for Inflammatory Bowel Disease in the ACG Self-Assessment Test subcommittee. His research interest is in sleep-related disorders in IBD patients. He is member of American College of Physicians, American Gastroenterological Association and Crohn’s and Colitis Foundation. He is an active member of the Govt. and Industry Affairs Committee and Diversity and Inclusion Taskforce of Crohn’s and Colitis Foundation. He is recognized as the community leader and moderator for the ACG and CCF IBD Circle, an online physician discussion forum. He regularly tweets through is educational twitter accounts @ibdtweets and the founder and moderator of social media international ibd journal club (@ibdclub). Dr. Ali is currently serving as the American College of Gastroenterology Governor for Oklahoma Chapter.
Hourly Schedule
Dinner Session
- 6:00 - 6:30
- Welcome
- Introduce IBDHorizons, Introduce attendees, moderators. Time for virtual exhibits
-
Speakers:
Anita Afzali-- MD-- MPH-- MHCM
- 6:30 - 8:00
- Present Three UC Cases
- Each followed by open discussion
-
Speakers:
Anita Afzali-- MD-- MPH-- MHCM, Tauseef Ali-- MD
- 8:00 - 8:30
- Closing remarks
-
Speakers:
Anita Afzali-- MD-- MPH-- MHCM
Not local?
Contact [email protected] to find out how we can bring a Dialogue to you.
- Accreditation: Non-accredited
-
Supporters:
Justin Morris Key Account Manager – Texas/Oklahoma
Takeda Pharmaceuticals U.S.A, Inc.
Mobile: 940-339-6496
Email: [email protected]
George Tosh District Business Manager-Dallas, TX-Pfizer Inc
[email protected] 727-267-7569